These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8991184)

  • 1. Altered physical state of p210bcr-abl in tyrphostin AG957-treated K562 cells.
    Kaur G; Sausville EA
    Anticancer Drugs; 1996 Nov; 7(8):815-24. PubMed ID: 8991184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
    Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA
    Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Munthe HA; Verfaillie CM
    Leukemia; 1998 Nov; 12(11):1708-17. PubMed ID: 9823945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro.
    Svingen PA; Tefferi A; Kottke TJ; Kaur G; Narayanan VL; Sausville EA; Kaufmann SH
    Clin Cancer Res; 2000 Jan; 6(1):237-49. PubMed ID: 10656455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different early effets of tyrphostin AG957 and geldanamycins on mitogen-activated protein kinase and p120cbl phosphorylation in anti CD-3-stimulated T-lymphoblasts.
    Losiewicz MD; Kaur G; Sausville EA
    Biochem Pharmacol; 1999 Feb; 57(3):281-9. PubMed ID: 9890555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of apoptosis by the tyrphostin AG957 in hematopoietic cells.
    Urbano A; Gorgun G; Foss F
    Biochem Pharmacol; 2002 Feb; 63(4):689-92. PubMed ID: 11992636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate.
    Anafi M; Gazit A; Zehavi A; Ben-Neriah Y; Levitzki A
    Blood; 1993 Dec; 82(12):3524-9. PubMed ID: 7505115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel 53 kDa protein complexed with P210bcr-abl in human chronic myelogenous leukemia cells.
    Li WJ; Kloetzer WS; Arlinghaus RB
    Oncogene; 1988 Jun; 2(6):559-66. PubMed ID: 3133627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase.
    Tauchi T; Feng GS; Shen R; Song HY; Donner D; Pawson T; Broxmeyer HE
    J Biol Chem; 1994 May; 269(21):15381-7. PubMed ID: 8195176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.
    Danhauser-Riedl S; Warmuth M; Druker BJ; Emmerich B; Hallek M
    Cancer Res; 1996 Aug; 56(15):3589-96. PubMed ID: 8758931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique.
    Shibata K; Nishimura J; Takahira H; Nawata H
    Leukemia; 1989 Sep; 3(9):615-9. PubMed ID: 2474729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.
    Dorsey JF; Jove R; Kraker AJ; Wu J
    Cancer Res; 2000 Jun; 60(12):3127-31. PubMed ID: 10866298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells.
    Hallek M; Danhauser-Riedl S; Herbst R; Warmuth M; Winkler A; Kolb HJ; Druker B; Griffin JD; Emmerich B; Ullrich A
    Br J Haematol; 1996 Jul; 94(1):5-16. PubMed ID: 8757502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of biosynthesis and phosphorylation of P210bcr/abl protein during differentiation induction of K 562 cells.
    Nishimura J; Takahira H; Shibata K; Muta K; Yamamoto M; Ideguchi H; Umemura T; Nawata H
    Leuk Res; 1988; 12(11-12):875-85. PubMed ID: 2464113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210(bcr/abl) initiated Ras signal transduction pathway.
    Wu LX; Xu JH; Wu GH; Chen YZ
    Acta Pharmacol Sin; 2003 Nov; 24(11):1155-60. PubMed ID: 14627502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.
    Freed E; Hunter T
    Mol Cell Biol; 1992 Mar; 12(3):1312-23. PubMed ID: 1545812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
    Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.
    Skorski T; Kanakaraj P; Ku DH; Nieborowska-Skorska M; Canaani E; Zon G; Perussia B; Calabretta B
    J Exp Med; 1994 Jun; 179(6):1855-65. PubMed ID: 8195713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.